Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current Assets
Cash	$ 51,100,915	$ 15,262,094
Accounts receivable, net	5,285,321	2,288,700
Related party receivables	366,590	225,693
Inventories, net	41,012,124	28,066,024
Prepaid expenses and other current assets	3,494,473	886,328
Total current assets	101,259,423	46,728,839
Restricted Cash	4,900,000	0
Property and equipment, net	27,030,400	23,189,730
Operating lease right-of-use asset, net	17,836,756	17,740,816
Finance lease right-of-use asset	883,076	767,237
Intangible assets, net	6,592,316	7,635,253
Goodwill	14,440,683	14,440,683
Investments	400,000	1,150,000
Equity-method investments	963,685	3,382,147
Other assets	993,538	454,429
Total assets	175,299,877	115,489,134
Current Liabilities
Accounts payable	16,889,756	8,691,430
Accrued payroll	2,526,917	2,592,143
Other accrued expenses	1,144,573	1,232,133
Related party payable	1,634,775	809,080
Current portion of operating lease liability	2,633,236	2,603,930
Current portion of finance lease liability	413,487	269,212
Current portion of long-term debt	494,173	223,400
Total current liabilities	25,736,917	16,421,328
Long-term Liabilities
Revolving line of credit		20,000,000
Operating lease liability, net of current portion	27,605,739	27,284,356
Finance lease liability, net of current portion	482,544	454,857
Long-term debt, net of current portion	1,083,634	469,471
Warrant liability	2,058,566	3,930,930
Other long-term liabilities		280,000
Total liabilities	56,967,400	68,840,942
Commitments and Contingencies (Notes 12 and 19)
Stockholders’ Equity (Deficit)
Additional paid-in capital	250,163,984	52,451,862
Accumulated deficit	(132,158,016)	(132,964,365)
Total stockholders’ equity (deficit)—Thorne HealthTech, Inc.	118,531,510	(80,389,265)
Non-controlling interest	(199,033)	(6,447,074)
Total stockholders’ equity (deficit)	118,332,477	(86,836,339)
Total liabilities, convertible preferred stock and stockholders’ equity (deficit)	175,299,877	115,489,134
Series E Preferred Stock [Member]
Long-term Liabilities
Series E convertible preferred stock; par value $0.01, 0 and 27,011,500 authorized as of December 31, 2021 and December 31, 2020, respectively; 0 and 27,011,500 issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; aggregate liquidation preference of $134,449,035 as of December 31, 2020		133,484,531
Common Class B [Member]
Stockholders’ Equity (Deficit)
Common Stock, value	0	0
Common Class Undefined [Member]
Stockholders’ Equity (Deficit)
Common Stock, value	$ 525,542	$ 123,238